Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The consecutive administration of Ginsenoside Rb2 also reduces virus titers in the bowels of RV-infected mice[2]
is a selective HECT E3 ubiquitin ligase inhibitor
Smiles: CC(C1CCN(CC1)S(=O)(=O)CC)N1C2=CC=CC=C2C(C(=O)NCC2=C(C=C(C)NC2=O)OC)=C1C
CAS Number: 1953130-87-4
Ro-3306 te N-desmethyl Netupitant The consecutive administration of GinsenosideRO 3306 is a CDK1 inhibitor with potential anticancer activity. Treatment of growing AML cells with RO 3306 induced G2 M phase cell cycle arrest and apoptosis in a dose and time dependent manner. RO 3306 downregulated expression of the antiapoptotic proteins Bcl 2 and survivin and blocked p53 mediated induction of p21 and MDM2. RO 3306 actively enhances downstream p53 signaling to promote apoptosis. Product information CAS Number: 872573 93 8
US$ 25.00
US$ 16.00
US$ 200.00
US$ 25.00
US$ 25.50
US$ 20.00
US$ 16.00
US$ 25.00
US$ 25.00
US$ 125.00
US$ 25.00
US$ 650.00
US$ 15.00
US$ 25.00